Cargando…

The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis

Objective: ANCA associated vasculitis (AAV) is characterized by systemic necrotizing vasculitis with the presence of ANCA. Although BPI-ANCA is one of the atypical ANCAs and is occasionally seen in patients with vasculitis, the pathogenicity of BPI-ANCA remains unclear. This study was performed to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeda, Sayo, Watanabe-Kusunoki, Kanako, Nakazawa, Daigo, Kusunoki, Yoshihiro, Nishio, Saori, Atsumi, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583233/
https://www.ncbi.nlm.nih.gov/pubmed/31249574
http://dx.doi.org/10.3389/fimmu.2019.01334
_version_ 1783428434731466752
author Takeda, Sayo
Watanabe-Kusunoki, Kanako
Nakazawa, Daigo
Kusunoki, Yoshihiro
Nishio, Saori
Atsumi, Tatsuya
author_facet Takeda, Sayo
Watanabe-Kusunoki, Kanako
Nakazawa, Daigo
Kusunoki, Yoshihiro
Nishio, Saori
Atsumi, Tatsuya
author_sort Takeda, Sayo
collection PubMed
description Objective: ANCA associated vasculitis (AAV) is characterized by systemic necrotizing vasculitis with the presence of ANCA. Although BPI-ANCA is one of the atypical ANCAs and is occasionally seen in patients with vasculitis, the pathogenicity of BPI-ANCA remains unclear. This study was performed to examine the pathogenic role of BPI-ANCA against neutrophils. Methods: A 76-year-old Japanese man showed BPI-ANCA positive systemic vasculitis with a medical history of Pseudomonas aeruginosa infection. BPI-ANCA IgGs were eluted from the patient serum using an immunoadsorbent column. In vitro experiment, healthy donor neutrophils were treated with BPI-AAV IgGs, MPO-AAV IgGs, healthy control IgGs under TNFα stimulation. After 3 h incubation, neutrophil extracellular trap (NET) was assessed by immunofluorescent imaging. To determine the pathogenicity of BPI-ANCA, TNFα-primed neutrophils were incubated with monoclonal BPI-ANCA in the presence or absence of recombinant BPI. Results: BPI-AAV IgGs-treated neutrophils showed NET formation with histone citrullination. Interestingly, the monoclonal BPI-ANCA did not induce NET, but the immune complexes (ICs) of recombinant BPI and BPI-ANCA induced TNFα-dependent NET formation with hypercitrullination. Furthermore, TNFα increased the expression of BPIs in neutrophils and the BPIs were translocated to cell surface. Conclusion: BPI-ANCA could affect neutrophils leading to NET formation and may play a role in the development of systemic vasculitis as pathogenic autoantibody.
format Online
Article
Text
id pubmed-6583233
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65832332019-06-27 The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis Takeda, Sayo Watanabe-Kusunoki, Kanako Nakazawa, Daigo Kusunoki, Yoshihiro Nishio, Saori Atsumi, Tatsuya Front Immunol Immunology Objective: ANCA associated vasculitis (AAV) is characterized by systemic necrotizing vasculitis with the presence of ANCA. Although BPI-ANCA is one of the atypical ANCAs and is occasionally seen in patients with vasculitis, the pathogenicity of BPI-ANCA remains unclear. This study was performed to examine the pathogenic role of BPI-ANCA against neutrophils. Methods: A 76-year-old Japanese man showed BPI-ANCA positive systemic vasculitis with a medical history of Pseudomonas aeruginosa infection. BPI-ANCA IgGs were eluted from the patient serum using an immunoadsorbent column. In vitro experiment, healthy donor neutrophils were treated with BPI-AAV IgGs, MPO-AAV IgGs, healthy control IgGs under TNFα stimulation. After 3 h incubation, neutrophil extracellular trap (NET) was assessed by immunofluorescent imaging. To determine the pathogenicity of BPI-ANCA, TNFα-primed neutrophils were incubated with monoclonal BPI-ANCA in the presence or absence of recombinant BPI. Results: BPI-AAV IgGs-treated neutrophils showed NET formation with histone citrullination. Interestingly, the monoclonal BPI-ANCA did not induce NET, but the immune complexes (ICs) of recombinant BPI and BPI-ANCA induced TNFα-dependent NET formation with hypercitrullination. Furthermore, TNFα increased the expression of BPIs in neutrophils and the BPIs were translocated to cell surface. Conclusion: BPI-ANCA could affect neutrophils leading to NET formation and may play a role in the development of systemic vasculitis as pathogenic autoantibody. Frontiers Media S.A. 2019-06-12 /pmc/articles/PMC6583233/ /pubmed/31249574 http://dx.doi.org/10.3389/fimmu.2019.01334 Text en Copyright © 2019 Takeda, Watanabe-Kusunoki, Nakazawa, Kusunoki, Nishio and Atsumi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Takeda, Sayo
Watanabe-Kusunoki, Kanako
Nakazawa, Daigo
Kusunoki, Yoshihiro
Nishio, Saori
Atsumi, Tatsuya
The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
title The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
title_full The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
title_fullStr The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
title_full_unstemmed The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
title_short The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
title_sort pathogenicity of bpi-anca in a patient with systemic vasculitis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583233/
https://www.ncbi.nlm.nih.gov/pubmed/31249574
http://dx.doi.org/10.3389/fimmu.2019.01334
work_keys_str_mv AT takedasayo thepathogenicityofbpiancainapatientwithsystemicvasculitis
AT watanabekusunokikanako thepathogenicityofbpiancainapatientwithsystemicvasculitis
AT nakazawadaigo thepathogenicityofbpiancainapatientwithsystemicvasculitis
AT kusunokiyoshihiro thepathogenicityofbpiancainapatientwithsystemicvasculitis
AT nishiosaori thepathogenicityofbpiancainapatientwithsystemicvasculitis
AT atsumitatsuya thepathogenicityofbpiancainapatientwithsystemicvasculitis
AT takedasayo pathogenicityofbpiancainapatientwithsystemicvasculitis
AT watanabekusunokikanako pathogenicityofbpiancainapatientwithsystemicvasculitis
AT nakazawadaigo pathogenicityofbpiancainapatientwithsystemicvasculitis
AT kusunokiyoshihiro pathogenicityofbpiancainapatientwithsystemicvasculitis
AT nishiosaori pathogenicityofbpiancainapatientwithsystemicvasculitis
AT atsumitatsuya pathogenicityofbpiancainapatientwithsystemicvasculitis